Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved ...
(MENAFN- 3BL) January 22, 2026 /3BL/ - Medtronic, a global leader in healthcare technology, announced verification study results for its investigational NellcorTM pulse oximetry with Nell-EQTM ...
Fingertip Blood Oxygen Monitors Are Less Accurate For People Of Color, Study Finds By Dennis Thompson HealthDay ReporterFRIDAY, Jan. 16, 2026 (HealthDay News) — Most everyone’s seen one in a doctor’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results